Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Minal K Patel"'
Publikováno v:
The Lancet Global Health, Vol 7, Iss 3, Pp e313-e320 (2019)
Summary: Background: Despite improvements in reported coverage of measles-containing vaccine (MCV) and progress towards elimination of measles, 172 939 measles cases were reported worldwide in 2017. Questions have been raised about whether measles ca
Externí odkaz:
https://doaj.org/article/2ab14546b6d24be09e4385699ef8127e
Autor:
Niklas Bobrovitz, Harriet Ware, Xiaomeng Ma, Zihan Li, Reza Hosseini, Christian Cao, Anabel Selemon, Mairead Whelan, Zahra Premji, Hanane Issa, Brianna Cheng, Laith J Abu Raddad, David L Buckeridge, Maria D Van Kerkhove, Vanessa Piechotta, Melissa M Higdon, Annelies Wilder-Smith, Isabel Bergeri, Daniel R Feikin, Rahul K Arora, Minal K Patel, Lorenzo Subissi
Publikováno v:
The Lancet Infectious Diseases. 23:556-567
Autor:
Daniel R. Feikin, Melissa M. Higdon, Nick Andrews, Shirley Collie, Maria Deloria Knoll, Jeffrey C. Kwong, Ruth Link-Gelles, Tamara Pilishvili, Minal K. Patel
Publikováno v:
Vaccine. 41:2329-2338
Autor:
Daniel R. Feikin, Laith J. Abu-Raddad, Nick Andrews, Mary-Ann Davies, Melissa M. Higdon, Walter A. Orenstein, Minal K. Patel
Publikováno v:
Vaccine. 40:3516-3527
Vaccine effectiveness is lower and wanes faster against infection and symptomatic disease caused by the omicron variant of SARS-CoV-2 than was observed with previous variants. Vaccine effectiveness against severe omicron disease, on average, is highe
Autor:
Melissa M Higdon, Anurima Baidya, Karoline K Walter, Minal K Patel, Hanane Issa, Emmanuelle Espié, Daniel R Feikin, Maria Deloria Knoll
Publikováno v:
The Lancet Infectious Diseases. 22:1114-1116
Autor:
Paul A. Rota, Minal K. Patel, Anindya Sekhar Bose, Allison Portnoy, Claudia Steulet, Marta Gacic-Dobo, Natasha S. Crowcroft, James Alexander, Alexander Rosewell, Mick N. Mulders, Sarah Hauryski, Meredith G Dixon, Matthew J. Ferrari, Katrina Kretsinger, Brian Lambert, Cynthia Hatcher, Xi Li, Yoann Nedelec, Sebastien Antoni
Publikováno v:
Morbidity and Mortality Weekly Report
In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan,* with the objective of eliminating measles† in five of the six World Health Organization (WHO) regions by 2020 (1). The Immunization Agenda 2021-2030 (IA2030)§ uses measle
Autor:
Minal K. Patel, Heather M. Scobie, Fatima Serhan, Benjamin Dahl, Christopher S. Murrill, Tomoka Nakamura, Sarah W. Pallas, Adam L. Cohen
Publikováno v:
Vaccine.
Autor:
Sudhir Joshi, Pasang Rai, Xiao Xian Huang, Jhalak Sharma Gautam, Binod Prasad Gupta, Anindya Sekhar Bose, Bhim Singh Tinkari, Adam L. Cohen, Jos Vandelaer, Minal K. Patel
Publikováno v:
Vaccine
Assessing the cost of vaccine preventable diseases (VPD) surveillance is becoming more important in the context of the Global Polio Eradication Initiative (GPEI) funding transition, since GPEI support to polio surveillance helped the incremental buil
Publikováno v:
International Journal of Epidemiology. 52:19-21
Autor:
Jeffrey McFarland, Claudia Steulet, Natasha S. Crowcroft, Samir V. Sodha, Katrina Kretsinger, James Alexander, Paul A. Rota, James L. Goodson, Lisa Menning, Marta Gacic-Dobo, Mick N. Mulders, Minal K. Patel
Publikováno v:
Morbidity and Mortality Weekly Report
In 2010, the World Health Assembly (WHA) set the following three milestones for measles control to be achieved by 2015: 1) increase routine coverage with the first dose of measles-containing vaccine (MCV1) among children aged 1 year to ≥90% at the